Monoclonal antibodies and plasmids services

Closed Solicitation Posted

Solicitation number
NOI-NIAID-24-2229841
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Rockville, Maryland 20852, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate an other than full and open competition basis with GenScript USA Incorporated to procure monoclonal antibodies and plasmids services. These services are necessary to identify and design vaccine candidates against COVID-19. The agency is seeking a service provider that can deliver customized gene to antibody, plasmid heavy chain, and plasmid light chain preparation. Key requirements include 178 units each of the specified services. The agency will consider capability statements from any responsible sources that could provide comparable products or services by the August 21, 2024 deadline.

This opportunity is not set aside for any specific business category. GenScript USA Incorporated is the incumbent contractor, and the period of performance is from September 20, 2024 to September 19, 2025. The place of performance is Rockville, MD. The NAICS code is 541380 - Testing Laboratories and Services, and the PSC code is Q301 - Reference Laboratory Testing.

Notice text

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate an other than full and open competition basis with GENSCRIPT USA INCORPORATED, 860 CENTENNIAL AVE, PISCATAWAY, NJ, 08854, United States, to procure MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES.
The Laboratory of Immunogenetics (LIG) focuses on the cellular and molecular mechanisms that underlie the signaling functions in immune cells. The LIG has recently expanded its focus to include work on developing novel vaccine candidates against different infectious diseases including COVID-19. These monoclonal antibodies and plasmids can be used to design new vaccine candidates and be tested for the ability to prevent the COVID-19 infection. These antibody and plasmid services are necessary to identify and design vaccine candidates against COVID-19. The Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG), in furtherance of its mission to advance our knowledge of human B cells and isolation of monoclonal antibodies requires a service that provides custom Gene to Antibodies, plasmid heavy chain, and plasmid light chain preparation. These custom antibody and plasmid services can be used to design new vaccine candidates against COVID-19. The ABU has been using GenScript for custom gene to antibody, and this is continuation of a master project that requires some additional work. Continuity is required to retain comparison of results.
Requirements List:
- SC1946-Ab-CHTP Gene to Antibody-Customized Service:rAb, QTY-178
- CloneArk Plasmid Preparation: rAb HC plasmid, Qty-178
Plasmid Size:0 Starting Material:Prepare at GenScript Copy number:High Template From:Current order:1 Quantity:100.000μg Quality grade:Research Grade (Predominantly supercoiled) Delivery form:Liquid Desired buffer:TE Required concentration:1 mg/ml Aliquot samples: Release Criteria:
-CloneArk Plasmid Preparation: rAb LC plasmid, QTY-178
Plasmid Size:0 Starting Material:Prepare at GenScript Copy number:High Template From:Current order:1 Quantity:100.000μg Quality grade:Research Grade (Predominantly supercoiled) Delivery form:Liquid Desired buffer:TE Required concentration:1 mg/ml Aliquot samples: Release Criteria:
Period of Performance: 9/20/24-9/19/2025
The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable product/services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2229841) to Angela Puddy at by 12:00 pm EASTERN Standard Time, Wednesday, August 21, 2024. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity